医学
经皮冠状动脉介入治疗
急性肾损伤
传统PCI
心肌梗塞
临床终点
优势比
内科学
随机对照试验
心脏病学
肾脏疾病
置信区间
入射(几何)
缺血预处理
冲程(发动机)
缺血
机械工程
物理
光学
工程类
作者
Ping Jia,Gang Zhao,Yuli Huang,Zhouping Zou,Qi Zeng,Weize Chen,Ting Ren,Yang Li,Xiaoyan Wang,Ting-Ting Kang,Zhihe Liu,Mengqing Ma,Jiwei Yu,Qiong Wu,Bing Deng,Xiaoxiang Yan,Xin Wan,Xin Chen,Changchun Cao,Junbo Ge
标识
DOI:10.1093/eurheartj/ehaf135
摘要
Abstract Background and Aims Remote ischaemic pre-conditioning (RIPC) delivered shortly prior to an angiographic procedure may reduce contrast-associated acute kidney injury (CA-AKI). Whether a longer interval between RIPC and contrast administration also reduces CA-AKI and post-procedural complications after coronary angiography (CAG) or percutaneous coronary intervention (PCI) is unknown. Methods This was a multicentre, randomized trial of patients at risk of CA-AKI undergoing elective CAG or PCI comparing delayed RIPC (four cycles of 5 min inflations on one upper arm 24 h before the procedure) with sham RIPC. The primary endpoint was the incidence of AKI, defined according to the Kidney Disease Improving Global Outcomes criteria. Secondary endpoints included renal replacement therapy during hospitalization, changes in urinary biomarkers of kidney injury, and occurrence of non-fatal myocardial infarction, stroke, re-hospitalization, and all-cause mortality by day 90. Results Altogether, 501 patients (age, 74 [66, 78] years) were randomly assigned to delayed (n = 250) or sham (n = 251) RIPC, of which 467 (93.2%) completed outcome assessments at day 90. The incidence of CA-AKI was 7.6% with sham and 3.2% with delayed RIPC (odds ratio 0.4, 95% confidence interval 0.17–0.94; P = .03). The trial was not adequately powered to show effects on secondary outcomes. Conclusions Among at-risk patients undergoing CAG or PCI, the incidence of CA-AKI was lower in patients receiving delayed compared with sham RIPC. These results should be confirmed in larger trials to investigate whether reductions in CA-AKI with delayed RIPC lead to important clinical benefits.
科研通智能强力驱动
Strongly Powered by AbleSci AI